Nanosensor Liquid Biopsy to Detect Cancer Biomarkers — Science Advances

Daniel A. Heller, PhD, and colleagues at Memorial Sloan Kettering Cancer Center published a study in Science Advances (November 2021) introducing a perception-based nanosensor platform for detecting cancer biomarkers, demonstrating that arrays of carbon nanotube sensors can generate composite molecular fingerprints without prior knowledge of which specific proteins or metabolites indicate disease. The work established the pattern-recognition architecture that underpins the Nine Diagnostics platform.